BRAVELLE Trademark

Trademark Overview

On Wednesday, October 26, 2022, a trademark application was filed for BRAVELLE with the United States Patent and Trademark Office. The USPTO has given the BRAVELLE trademark a serial number of 97648987. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, October 29, 2024. This trademark is owned by Ferring B.V.. The BRAVELLE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for treating infertility
bravelle

General Information

Serial Number97648987
Word MarkBRAVELLE
Filing DateWednesday, October 26, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, October 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2023

Trademark Statements

Goods and Servicespharmaceutical preparations for treating infertility

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameFerring B.V.
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132JX
NL
Party NameFerring B.V.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHoofddorp 2132 JX
NL

Trademark Events

Event DateEvent Description
Saturday, October 29, 2022NEW APPLICATION ENTERED
Monday, October 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 19, 2023ASSIGNED TO EXAMINER
Thursday, April 20, 2023NON-FINAL ACTION WRITTEN
Thursday, April 20, 2023NON-FINAL ACTION E-MAILED
Thursday, April 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 17, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 17, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 19, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 19, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 15, 2024SOU EXTENSION 1 FILED
Friday, March 15, 2024SOU EXTENSION 1 GRANTED
Saturday, March 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, July 1, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 29, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 29, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 29, 2024SOU EXTENSION 2 FILED
Tuesday, October 29, 2024SOU EXTENSION 2 GRANTED

Related Keywords

bravelle infertility treating preparations pharmaceutical